Filing Details
- Accession Number:
- 0001127602-20-008931
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-03-03 16:02:24
- Reporting Period:
- 2020-03-02
- Accepted Time:
- 2020-03-03 16:02:24
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1082554 | United Therapeutics Corp | UTHR | Pharmaceutical Preparations (2834) | 521984749 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1324863 | G Tommy Thompson | 1040 Spring St. Silver Spring MD 20910 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-03-02 | 8,500 | $51.77 | 30,440 | No | 4 | M | Direct | |
Common Stock | Disposition | 2020-03-02 | 4,290 | $103.59 | 26,150 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Options | Disposition | 2020-03-02 | 8,500 | $0.00 | 8,500 | $51.77 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2011-06-28 | 2020-06-28 | No | 4 | M | Direct |
Footnotes
- Represents a cashless exercise-and-hold, where enough shares were sold to cover the exercise price and anticipated taxes, and the remaining shares were held by the reporting person.
- This transaction was executed in multiple trades at prices ranging from $103.54 to $103.77. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.